Cargando…
Recent Advances in the Surface Functionalization of PLGA-Based Nanomedicines
Therapeutics are habitually characterized by short plasma half-lives and little affinity for targeted cells. To overcome these challenges, nanoparticulate systems have entered into the disease arena. Poly(d,l-lactide-co-glycolide) (PLGA) is one of the most relevant biocompatible materials to constru...
Autores principales: | El-Hammadi, Mazen M., Arias, José L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840194/ https://www.ncbi.nlm.nih.gov/pubmed/35159698 http://dx.doi.org/10.3390/nano12030354 |
Ejemplares similares
-
PLGA-Based Nanomedicine: History of Advancement and Development in Clinical Applications of Multiple Diseases
por: Alsaab, Hashem O., et al.
Publicado: (2022) -
Recent Advances in Magnetite Nanoparticle Functionalization for Nanomedicine
por: Popescu, Roxana Cristina, et al.
Publicado: (2019) -
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles
por: Vilella, Antonietta, et al.
Publicado: (2015) -
Natural product-based nanomedicine: recent advances and issues
por: Watkins, Rebekah, et al.
Publicado: (2015) -
Recent Advancements in Nanomedicine for ‘Cold’ Tumor Immunotherapy
por: Chen, Qinjun, et al.
Publicado: (2021)